Signifies the first major step towards the application process for the certification of its
Mango ED oral dissolvable products by Mexico's health governing agency, COFEPRIS
Dallas, Texas, April 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that its subsidiary, MangoRx Mexico S.A. de C.V. ("MangoRx Mexico"), has secured and executed a technical agreement with Emifarma S.A. de C.V ("Emifarma...
Login or create a forever free account to read this news
Sign up/Log in